Full-Time

Senior Quality Assurance Automation Engineer

Posted on 2/3/2026

Radformation

Radformation

51-200 employees

FDA-cleared software for radiation therapy planning

Compensation Overview

$100k - $160k/yr

Remote in USA

Remote

Category
QA & Testing (1)
Required Skills
Python
Java
Quality Assurance (QA)
C#
Requirements
  • 5+ years in software test automation or software engineering in test
  • Hands-on verification and validation (V&V) experience
  • Programming automated testing in Python, C#, Java, or similar
  • Experience using AI-assisted developer tools for test automation (e.g., AI code generation, test creation, or test maintenance for UI automation)
  • Experience with automation frameworks/tools for UI testing (e.g., Katalon, Ranorex, WinAppDriver, FlaUI, SmartBear TestComplete, Cypress)
  • Strong problem-solving and critical thinking skills
  • Clear communication and collaboration with cross-functional teams
  • Ability to multitask and work independently in a fast-paced environment
  • Detail-oriented documentation of test plans, cases, and results
  • Bachelor’s degree in Computer Science, Engineering, or a related technical field
Responsibilities
  • Design, implement, and own test automation frameworks from the ground up, including identifying, prioritizing, and converting manual test coverage into reliable automated tests
  • Create scalable test scripts for regression, functional, and UI testing
  • Coordinate with Product to ensure testing considerations are integrated from requirements through release
  • Develop and execute automated tests for each product version prior to release (Python, C#, Java, or similar)
  • Troubleshoot and debug test failures, working with Product and Engineering to isolate root causes
  • Incorporate incoming customer-reported issues into automated test coverage
  • Generate and maintain documentation for test plans, test cases, and automated test results
  • Evaluate, integrate, and maintain automation tools (applications, scripts, dashboards) to increase QA team efficiency
  • Create and maintain controlled test environments to catch issues early and enable reliable product deployment
  • Work with Product and Regulatory teams to ensure verification and validation (V&V) activities are documented for compliance
Desired Qualifications
  • Lead or senior QA automation engineer experience across multiple products
  • Familiarity with FDA Class IIa+ regulated medical device software
  • Building automation frameworks and integrating CI/CD pipelines
  • Testing SaaS, cloud, and/or web applications at scale, including performance
  • Agile development experience (acceptance criteria and deliverables)
  • Domain knowledge in healthcare software, preferably radiation oncology
  • Experience with Jira, Visual Studio, Matrix ALM, or similar tools

Radformation provides FDA-cleared software tools for radiation therapy treatment planning to help clinics improve quality and efficiency. Its product suite includes ClearCheck for automated plan checks and documentation, ClearCalc for independent dose validation, EZFluence for generating 3D treatment plans, AutoContour an AI-driven contouring tool, ChartCheck for real-time patient data monitoring, and QuickCode for billing QA. These tools integrate into existing clinical workflows and are offered via software licenses with support services. Compared to competitors, Radformation offers a cohesive, FDA-cleared, multi-tool platform that covers plan checks, dose validation, plan generation, AI-assisted contouring, data monitoring, and billing QA in one ecosystem. The company’s goal is to streamline the entire treatment planning process, helping radiation oncology departments save time and resources while ensuring accurate, high-quality patient care.

Company Size

51-200

Company Stage

Early VC

Total Funding

$9.2M

Headquarters

New York City, New York

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Limbus AI acquisition expands AI contouring to serve 2,000 global clinics.
  • Icon Group deploys ChartCheck Adaptive across 15 Australian centers since November.
  • Regulatory clearances in Australia, Brazil, Canada, Thailand boost international sales.

What critics are saying

  • Varian's ARIA Eclipse AI tools lock clinics into ecosystems within 12-24 months.
  • MIM Software's superior AI contouring causes AutoContour customer churn in 6-12 months.
  • RaySearch RayStation native automation halves addressable market in 18-36 months.

What makes Radformation unique

  • Radformation offers vendor-neutral automation integrating with Eclipse, RayStation, and Monaco TPS.
  • FDA-cleared suite includes AutoContour AI contouring, EZFluence 3D planning, and ClearCheck checks.
  • Founders' physicist backgrounds drive error reduction in radiation therapy workflows since 2016.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Parental Leave

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

13%
Business Wire
Feb 18th, 2026
Icon Group deploys ChartCheck Adaptive across 15 Australian cancer centres as Radformation gains US FDA 510(k) clearance

Icon Group has deployed ChartCheck Adaptive, Radformation's offline adaptive assessment solution, across 15 cancer centres in Australia. The rollout began in November and will expand to all Icon Cancer Centre locations globally in the coming months. The technology provides automated, quantitative insight into daily treatment delivery, particularly benefiting head and neck cancer cases. Early results show several patients were successfully re-planned due to anatomical changes during treatment, supporting clinical decision-making whilst maintaining efficient workflows. Radformation has secured expanded US FDA 510(k) clearance for ChartCheck to support the new adaptive functionality. The software evaluates daily imaging and treatment data to assess how dose and anatomy change throughout treatment. Icon Group, serving over 55 cancer centres globally, has partnered with Radformation as an early adopter and Centre of Excellence member.

Radformation
Jan 7th, 2025
Upcoming Release: AutoContour v2.6 Offers 95 Brand New Structure Models

Radformation is thrilled to announce the upcoming release of AutoContour v2.6, packed with exciting features, enhancements, and additional structure models.

Business Wire
May 3rd, 2024
Radformation to Accelerate AI-Based Solutions with Limbus AI Acquisition

Radformation, Inc. has acquired Limbus AI. This merger combines their strengths to advance AI-driven solutions, aiming to enhance patient care.

Business Wire
May 1st, 2024
Radformation Acquires Limbus AI

Radformation, a leader in cancer care automation, has acquired Limbus AI, a top provider of automated contouring software for radiation therapy. This merger enhances Radformation's AI capabilities and aims to integrate the best features of both companies' technologies, promising advancements in radiation therapy. The combined entity will now serve over 2,000 clinics globally, impacting 500,000 patients. This strategic move is set to drive innovation and improve patient outcomes in healthcare technology.

Business Wire
Feb 22nd, 2024
Radformation Recebe Autorizações Regulatórias Para Soluções De Automação Na Austrália, Brasil, Canadá E Tailândia

NOVA YORK--(BUSINESS WIRE)--Radformation, líder em soluções de software clínico e operacional para tratamento do câncer, anunciou hoje que recebeu autorizações regulatórias para suas soluções de automação de radioterapia* da Therapeutic Goods Administration (TGA) na Austrália, da Agência Nacional de Vigilância Sanitária (ANVISA) no Brasil, da Health Canada no Canadá e da Administração de Alimentos e Medicamentos (FDA) na Tailândia. “Essas autorizações refletem nosso compromisso com a inovação global em saúde e nossa dedicação em atender aos rigorosos padrões regulatórios essenciais para melhorar o atendimento aos pacientes no mundo inteiro”, disse Kurt Sysock, CEO da Radformation. Incluído nessas autorizações está o AutoContour, a solução de segmentação e perfilamento automática baseada em IA da Radformation, projetado para iniciar o processo de planejamento do tratamento. Em um estudo de caso recente, o AutoContour demonstrou diminuir o tempo de planejamento do perfilamento em uma média de 84% em todos os locais anatômicos, gerando perfilamentos altamente precisos, levando a uma melhor consistência do plano de tratamento. Os primeiros usuários brasileiros do AutoContour e do ClearCheck, o software automatizado de verificação de plano secundário da Radformation, a Liga Catarinense de Combate ao Câncer - Radioterapia São Sebastião e o Real Hospital Português de Beneficência, selecionaram as ferramentas da Radformation para complementar suas crescentes modalidades de tratamento de última geração e expandir a carga de pacientes

INACTIVE